The results of this study also indicated an increase in BHLHE41/DEC2 expression using quantitative PCR of 50 clinical samples and immunoblotting of five pairs of RCC-positive and adjacent normal kidneys [26]. The gene discussed is BHLHE41; the disease is renal cell adenocarcinoma.